Avoidable Mortality: The Core of the Global Cancer Divide

Abstract

PurposeThe incidence of infection-associated cancers and lethality of cancers amenable to treatment are closely correlated with the income of countries. We analyzed a core part of this global cancer divide—the distribution of premature mortality across country income groups and cancers—applying novel approaches to measure avoidable mortality and identify priorities for public policy.MethodsWe analyzed avoidable cancer mortality using set lower- and upper-bound age limits of 65 and 75 years (empirical approach), applying cancer-specific and country income group–specific ages of death (feasibility approach), and applying cancer-specific ages of death of high-income countries to all low- and middle-income countries (LMICs; social justice approach). We applied these methods to 2015 mortality data on 16 cancers for which prevention is possible and/or treatment is likely to result in cure or significant increase in life expectancy.ResultsAt least 30% and as much as 50% of cancer deaths are premature, corresponding to between 2.6 and 4.3 million deaths each year, and 70% to 80% are concentrated in LMICs. Using the feasibility approach, 36% of cancer deaths are avoidable; with the social justice approach, 45% of cancer deaths are avoidable. Five cancer types—breast, colorectal, lung, liver, and stomach—account for almost 75% of avoidable cancer deaths in LMICs and worldwide.ConclusionEach year, millions of premature cancer deaths could be avoided with interventions focused on four priority areas: infection-associated cancers, lifestyle and risk factors, women’s cancers, and children’s cancers. Our analysis of the global burden and the specific cancer types associated with avoidable cancer mortality suggests significant opportunities for health systems to redress the inequity of the global cancer divide.

Effects of a WhatsApp-Delivered Education Intervention to Enhance Breast Cancer Knowledge in Women: Mixed-Methods Study

“…Breast cancer represents the main cause of death by cancer among women around the world [ 1 ]. The mortality rates associated with this malignancy are higher in low- and middle-income countries owing to early diagnosis deficiencies and low access to treatment [ 2 , 3 ]. Mortality reduction in many developed countries has been occurring after the implementation of organized screening of precursor lesions associated with more effective therapies [ 4 - 6 ].…”

Evidence for the path to cervical cancer elimination

“…Cervical cancer is one of the top five cancers with the greatest proportion of avoidable cancer mortalitypremature deaths resulting from health system failures that could otherwise be avoided on the basis of existing medical advancements and with access to high-quality health care. 4 As evidenced by the importance of quality markers in health care, including the effectiveness and timeliness of care, 5 an immense opportunity exists to bridge the gap in what can be achieved and what is achieved on the prevention and treatment of cervical cancer. Fundamental to any response is reliable assessment of the global burden of cervical cancer.…”

Moral Distress and Resilience Associated with Cancer Care Priority Setting in a Resource-Limited Context

“…Although major progress has been achieved in the fight against cancer, many services are still not widely available in LMICs [ 14 ]. Vast disparities in access to preventive measures, screening, early detection, and effective treatment translate into millions of avoidable and premature deaths [ 15 ]. In Africa, the cancer burden is steadily rising, and health care systems are inadequately equipped to meet population needs [ 16 ].…”